GH Research (GHRS) Common Equity (2020 - 2025)

GH Research (GHRS) recorded quarterly Common Equity of $279.7 million in Q4 2025, up 56.3% quarter-over-quarter from $179.0 million in Q4 2024, and up 56.3% on a YoY basis from $179.0 million in Q4 2024.

GH Research (GHRS) Common Equity (2020 - 2025) Analysis & Trends

GH Research's Common Equity history runs 6 years deep, the most recent figure standing at $279.7 million for Q4 2025.

  • In Q4 2025, Common Equity rose 56.3% year-over-year to $279.7 million; the TTM figure through Dec 2025 stood at $279.7 million (up 56.3% YoY), while the FY2025 annual figure was $279.7 million, up 56.3% from the prior year.
  • Common Equity was $279.7 million for Q4 2025 at GH Research, up from $179.0 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $279.7 million in Q4 2025 to a low of $179.0 million in Q4 2024.
  • Historically, Common Equity has averaged $240.9 million across 5 years, with a median of $249.8 million in 2022.
  • The sharpest annual moves came in 2021 and 2024: Common Equity soared 4791.9% in 2021, then decreased 18.28% in 2024.
  • A 5-year view of Common Equity shows it stood at $277.2 million in 2021, then dropped by 9.87% to $249.8 million in 2022, then declined by 12.35% to $219.0 million in 2023, then dropped by 18.28% to $179.0 million in 2024, then surged by 56.3% to $279.7 million in 2025.
  • The last three Common Equity figures came in at $279.7 million (Q4 2025), $179.0 million (Q4 2024), and $219.0 million (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 35.63 Mn
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -1.42 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 14.38 Mn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - 13.21 Mn
7 Psyence Biomedical 241.78 Bn 241.78 Bn - 11.87 Mn
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 19.36 Bn
9 Abivax 94.26 Bn 94.26 Bn - -
10 GH Research 9.73 Bn 9.63 Bn - 279.70 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 279.70 Mn
Dec 31, 2024 178.95 Mn
Dec 31, 2023 218.97 Mn
Dec 31, 2022 249.82 Mn
Dec 31, 2021 277.18 Mn
Dec 31, 2020 5.67 Mn